Division of Pediatric Nephrology, Emory University, 2015 Uppergate Drive, NE, Atlanta, GA 30322, USA.
Clin J Am Soc Nephrol. 2011 Jan;6(1):14-21. doi: 10.2215/CJN.08481109. Epub 2010 Oct 28.
Poor linear growth is a well described complication of chronic kidney disease (CKD). This study evaluated whether abnormal birth history defined by low birth weight (LBW; <2500 g), prematurity (gestational age <36 weeks), small for gestational age (SGA; birth weight <10th percentile for gestational age), or intensive care unit (ICU) at birth were risk factors for poor growth outcomes in children with CKD.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Growth outcomes were quantified by age-sex-specific height and weight z-scores during 1393 visits from 426 participants of the Chronic Kidney Disease in Children Study, an observational cohort of children with CKD. Median baseline GFR was 42.9 ml/min per 1.73 m(2), 21% had a glomerular diagnosis, and 52% had CKD for ≥ 90% of their lifetime.
A high prevalence of LBW (17%), SGA (14%), prematurity (12%), and ICU after delivery (40%) was observed. Multivariate analyses demonstrated a negative effect of LBW (-0.43 ± 0.14; P < 0.01 for height and -0.37 ± 0.16; P = 0.02 for weight) and of SGA (-0.29 ± 0.16; P = 0.07 for height and -0.41 ± 0.19; P = 0.03 for weight) on current height and weight. In children with glomerular versus nonglomerular diagnoses, the effect of SGA (-1.08 versus -0.18; P = 0.029) on attained weight was more pronounced in children with a glomerular diagnosis.
LBW and SGA are novel risk factors for short stature and lower weight percentiles in children with mild to moderate CKD independent of kidney function.
慢性肾脏病(CKD)患者的线性生长不良是一种常见并发症。本研究旨在评估出生时体重低(LBW,<2500g)、早产(胎龄<36 周)、小于胎龄儿(SGA,出生体重<胎龄第 10 百分位数)或出生后入住重症监护病房(ICU)等异常出生史是否为 CKD 患儿生长不良的危险因素。
设计、地点、参与者和测量:通过 426 名慢性肾脏病儿童研究(CKD 儿童观察队列)参与者的 1393 次就诊,采用年龄性别特异性身高和体重 z 评分来量化生长结局。中位基线肾小球滤过率(GFR)为 42.9ml/min/1.73m²,21%为肾小球疾病,52%患儿 CKD 持续时间≥90%。
观察到 LBW(17%)、SGA(14%)、早产(12%)和分娩后 ICU(40%)的高患病率。多变量分析显示,LBW(身高-0.43±0.14;P<0.01,体重-0.37±0.16;P=0.02)和 SGA(身高-0.29±0.16;P=0.07,体重-0.41±0.19;P=0.03)对当前身高和体重均有负面影响。在肾小球疾病与非肾小球疾病患儿中,SGA(-1.08 与-0.18;P=0.029)对体重的影响在肾小球疾病患儿中更为显著。
LBW 和 SGA 是轻度至中度 CKD 患儿身材矮小和体重百分位数较低的新危险因素,与肾功能无关。